, and the 36-month beta value for DHC is at 1.86. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price suggested by analysts for DHC is $2.70, which is -$0.18 below the current market price. The public float for DHC is 215.68M, and currently, shorts hold a 2.47% of that float. The average trading volume for DHC on September 18, 2023 was 2.17M shares.
DHC) stock’s latest price update
Diversified Healthcare Trust (NASDAQ: DHC)’s stock price has decreased by -8.33 compared to its previous closing price of 2.52. However, the company has seen a 0.43% increase in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-09-13 that Diversified Healthcare (DHC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
DHC’s Market Performance
DHC’s stock has risen by 0.43% in the past week, with a monthly drop of -15.38% and a quarterly drop of -19.51%. The volatility ratio for the week is 7.24% while the volatility levels for the last 30 days are 7.76% for Diversified Healthcare Trust The simple moving average for the last 20 days is -13.25% for DHC stock, with a simple moving average of 50.44% for the last 200 days.
Analysts’ Opinion of DHC
Many brokerage firms have already submitted their reports for DHC stocks, with Wells Fargo repeating the rating for DHC by listing it as a “Underweight.” The predicted price for DHC in the upcoming period, according to Wells Fargo is $4 based on the research report published on December 10, 2020 of the previous year 2020.
DHC Trading at -11.71% from the 50-Day Moving Average
After a stumble in the market that brought DHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.00% of loss for the given period.
Volatility was left at 7.76%, however, over the last 30 days, the volatility rate increased by 7.24%, as shares sank -15.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.43% upper at present.
During the last 5 trading sessions, DHC rose by +0.43%, which changed the moving average for the period of 200-days by +136.51% in comparison to the 20-day moving average, which settled at $2.64. In addition, Diversified Healthcare Trust saw 257.14% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at DHC starting from PORTNOY ADAM D., who purchase 2,000,000 shares at the price of $3.07 back on Jun 14. After this action, PORTNOY ADAM D. now owns 23,250,019 shares of Diversified Healthcare Trust, valued at $6,132,600 using the latest closing price.
PORTNOY ADAM D., the Director of Diversified Healthcare Trust, purchase 1,992,259 shares at $3.03 during a trade that took place back on Jun 13, which means that PORTNOY ADAM D. is holding 21,250,019 shares at $6,026,783 based on the most recent closing price.
Stock Fundamentals for DHC
Current profitability levels for the company are sitting at:
- -9.31 for the present operating margin
- -5.05 for the gross margin
The net margin for Diversified Healthcare Trust stands at -1.23. The total capital return value is set at -1.98, while invested capital returns managed to touch -0.27. Equity return is now at value -10.40, with -4.70 for asset returns.
Based on Diversified Healthcare Trust (DHC), the company’s capital structure generated 116.53 points at debt to equity in total, while total debt to capital is 53.82. Total debt to assets is 51.23, with long-term debt to equity ratio resting at 106.43. Finally, the long-term debt to capital ratio is 49.15.
When we switch over and look at the enterprise to sales, we see a ratio of 2.17, with the company’s debt to enterprise value settled at 1.21. The receivables turnover for the company is 15.35 and the total asset turnover is 0.20.
In conclusion, Diversified Healthcare Trust (DHC) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.